Page 427 - Multidisipliner Covid 19

COVID-19 ve Endokrin Sistem Hastal›klar›

Üniversitesi Tıp Fakültesi Dergisi.2019; 45(2): 219-223. doi: 10.32708/
uutfd.529506.
31. D'Avolio A, Avataneo V, Manca A, et al. 25-Hydroxyvitamin D Concen-
trations Are Lower in Patients with Positive PCR for SARS-CoV-2.
Nutrients. 2020;12(5):E1359. doi: 10.3390/nu12051359.
32. Carter SJ, Baranauskas MN, Fly AD. Considerations for Obesity, Vita-
min D, and Physical Activity Amid the COVID-19 Pandemic. Obesity
(Silver Spring). 2020. doi: 10.1002/oby.22838.
33. Leow MK, Kwek DS, Ng AW, Ong KC, Kaw GJ, Lee LS. Hypocortisolism
in survivors of severe acute respiratory syndrome (SARS). Clin Endo-
crinol (Oxf). 2005;63(2):197-202. doi: 10.1111/j.1365-2265.2005.02325.x.
34. Wheatland R. Molecular Mimicry of ACTH in SARS- Implications for
Corticosteroid Treatment and Prophylaxis. Med Hypotheses. 2004;63
(5):855-62. doi: 10.1016/j.mehy.2004.04.009
35. Pal R. COVID-19, hypothalamo-pituitary-adrenal axis and clinical
implications. Endocrine. 2020;68(2):251-252. doi: 10.1007/s12020-020-
02325-1.
36. Russell CD, Millar JE, Baillie JK. Clinical evidence does not support
corticosteroid treatment for 2019-nCoV lung injury. Lancet. 2020;395
(10223):473-475. doi: 10.1016/S0140-6736(20)30317-2.
37. Panesar NS. What caused lymphopenia in SARS and how reliable is
the lymphokine status in glucocorticoid-treated patients? Med Hypothe-
ses. 2008;71(2):298-301. doi: 10.1016/j.mehy.2008.03.019.
38. Isidori AM, Pofi R, Hasenmajer V, Lenzi A, Pivonello R. Use of gluco-
corticoids in patients with adrenal insufficiency and COVID-19 infection.
Lancet Diabetes Endocrinol. 2020;8(6):472-473. doi: 10.1016/S2213-
8587(20)30149-2.
39. Prete A, Taylor AE, Bancos I, et al. Prevention of Adrenal Crisis: Cortisol
Responses to Major Stress Compared to Stress Dose Hydrocortisone
Delivery. J Clin Endocrinol Metab. 2020;105(7):dgaa133. doi: 10.1210/
clinem/dgaa133.
40. Isidori AM, Minnetti M, Sbardella E, Graziadio C, Grossman AB.
Mechanisms in endocrinology: The spectrum of haemostatic abnormali-
ties in glucocorticoid excess and defect.Eur J Endocrinol. 2015;173(3):
R101-13. doi: 10.1530/EJE-15-0308.
41. Kaiser UB, Mirmira RG, Stewart PM. Our Response to COVID-19 as
Endocrinologists and Diabetologists. J Clin Endocrinol Metab.

426